A Systematic Review of Probiotic Interventions for Gastrointestinal Symptoms and Irritable Bowel Syndrome in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME)

Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review

(2017) N. Campagnolo et al.   JOURNAL OF HUMAN NUTRITION AND DIETETICS

Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study

(2017) L. Vork et al.   NEUROGASTROENTEROLOGY AND MOTILITY

A Systematic Review of Drug Therapies for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis

(2016) Ansel Collatz et al.   CLINICAL THERAPEUTICS

Rome IV—Functional GI Disorders: Disorders of Gut-Brain Interaction

(2016) Douglas A. Drossman et al.   GASTROENTEROLOGY

A Randomized, Double-Blind, Placebo-Controlled Trial: The Efficacy of Multispecies Probiotic Supplementation in Alleviating Symptoms of Irritable Bowel Syndrome Associated with Constipation

(2016) Valerio Mezzasalma et al.   Biomed Research International

Epidemiological characteristics of chronic fatigue- syndrome/myalgic encephalomyelitis in Australian patients

(2016) Samantha Johnston et al.   Clinical Epidemiology

Lactobacillus paracasei F19 versus placebo for the prevention of proton pump inhibitor-induced bowel symptoms: A randomized clinical trial

(2015) Debora Compare et al.   DIGESTIVE AND LIVER DISEASE

A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome

(2015) Guillaume Pineton de Chambrun et al.   DIGESTIVE AND LIVER DISEASE

Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled pilot clinical study

(2015) Muhammed Majeed et al.   Nutrition Journal

Randomised clinical trial: a liquid multi-strain probiotic vs. placebo in the irritable bowel syndrome - a 12 week double-blind study

(2014) G. Sisson et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Effects of 12 weeks of probiotic supplementation on quality of life in colorectal cancer survivors: A double-blind, randomized, placebo-controlled trial

(2014) Jee-Yon Lee et al.   DIGESTIVE AND LIVER DISEASE

Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome

(2014) Zaigham Abbas et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

High-throughput 16S rRNA gene sequencing reveals alterations of intestinal microbiota in myalgic encephalomyelitis/chronic fatigue syndrome patients

(2013) Marc Frémont et al.   ANAEROBE

Long-term treatment with probiotics in primary care patients with irritable bowel syndrome – a randomised, double-blind, placebo controlled trial

(2013) Luise Mølenberg Begtrup et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

The prevalence of chronic fatigue syndrome/ myalgic encephalomyelitis: a meta-analysis

(2013) Samantha Johnston et al.   Clinical Epidemiology

A randomised clinical trial (RCT) of a symbiotic mixture in patients with irritable bowel syndrome (IBS): effects on symptoms, colonic transit and quality of life

(2012) Carmelina Cappello et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: A randomized, double-blind study

(2012) Michel Dapoigny   WORLD JOURNAL OF GASTROENTEROLOGY

Clinical trial:Lactobacillus plantarum299v (DSM 9843) improves symptoms of irritable bowel syndrome

(2012) Philippe Ducrotté   WORLD JOURNAL OF GASTROENTEROLOGY

Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life -- a double-blind, placebo-controlled study

(2011) S. Guglielmetti et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome

(2011) Wolfgang Kruis et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Probiotic Bacteria Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07 Versus Placebo for the Symptoms of Bloating in Patients With Functional Bowel Disorders

(2011) Tamar Ringel-Kulka et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

The Effect of a Multispecies Probiotic Mixture on the Symptoms and Fecal Microbiota in Diarrhea-dominant Irritable Bowel Syndrome

(2011) Bong Ki Cha et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Myalgic encephalomyelitis: International Consensus Criteria

(2011) B. M. Carruthers et al.   JOURNAL OF INTERNAL MEDICINE

A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial

(2010) Solveig C Ligaarden et al.   BMC GASTROENTEROLOGY

Clinical Trial on the Efficacy of a New Symbiotic Formulation, Flortec, in Patients With Irritable Bowel Syndrome

(2010) Angelo Andriulli et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Guidelines for Glycerol Use in Hyperhydration and Rehydration Associated with Exercise

(2010) Simon Piet van Rosendal et al.   SPORTS MEDICINE

Clinical trial: the effect of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome (IBS) - a randomized, double-blind, controlled study

(2009) M. SIMRÉN et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Effect of supplement with lactic-acid producing bacteria on fatigue and physical activity in patients with chronic fatigue syndrome

(2009) Åsa Sullivan et al.   Nutrition Journal

Randomized Controlled Treatment Trial of Irritable Bowel Syndrome with a Probiotic E.-coli Preparation (DSM17252) Compared to Placebo

(2009) P Enck et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE

Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome

(2008) J. ZENG et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study

(2008) E. A. WILLIAMS et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A mixture ofEscherichia coli(DSM 17252) andEnterococcus faecalis(DSM 16440) for treatment of the irritable bowel syndrome - A randomized controlled trial with primary care physicians

(2008) p. enck et al.   NEUROGASTROENTEROLOGY AND MOTILITY